A key mechanism driving the early progression from MASLD to metabolic-associated steatohepatitis (MASH) in mice involves the release of high mobility group box 1(HMGB1) from injured hepatocytes. This evidence concerns the gene HMGB1 and metabolic dysfunction-associated steatotic liver disease.